Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance
about
Major determinants for the selecting antithrombotic therapies in patients with nonvalvular atrial fibrillation in Japan (JAPAF study).Bleeding with oral anticoagulant dabigatran is highly associated with occult cancers in atrial fibrillation patients.Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa.
P2860
Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Post-marketing surveillance on ...... the J-dabigatran surveillance
@ast
Post-marketing surveillance on ...... the J-dabigatran surveillance
@en
type
label
Post-marketing surveillance on ...... the J-dabigatran surveillance
@ast
Post-marketing surveillance on ...... the J-dabigatran surveillance
@en
prefLabel
Post-marketing surveillance on ...... the J-dabigatran surveillance
@ast
Post-marketing surveillance on ...... the J-dabigatran surveillance
@en
P2093
P2860
P1476
Post-marketing surveillance on ...... the J-dabigatran surveillance
@en
P2093
Hiroshi Inoue
Hirotsugu Atarashi
J-Dabigatran Surveillance Investigators
Ken Okumura
Makiko Ohnishi
Masahiro Yasaka
Nobutaka Yagi
Shinichiro Uchiyama
Takeshi Yamashita
Taku Fukaya
P2860
P304
P356
10.1016/J.JOA.2015.11.008
P577
2016-01-16T00:00:00Z